Congestion and Use of Diuretics in Heart Failure and Cardiomyopathies: a Practical Guide.


Journal

Current cardiology reports
ISSN: 1534-3170
Titre abrégé: Curr Cardiol Rep
Pays: United States
ID NLM: 100888969

Informations de publication

Date de publication:
05 2023
Historique:
accepted: 19 03 2023
medline: 17 5 2023
pubmed: 19 4 2023
entrez: 19 04 2023
Statut: ppublish

Résumé

Heart failure is a highly prevalent condition caused by many different aetiologies and characterised by cardiac dysfunction and congestion. Once developed, congestion leads to signs (peripheral oedema) and symptoms (breathlessness on exertion), adverse cardiac remodelling, and an increased risk of hospitalisation and premature death. This review summarises strategies that could enable early identification and a more objective management of congestion in patients with heart failure. For patients with suspected or diagnosed heart failure, combining an echocardiogram with assessment of great veins, lungs, and kidneys by ultrasound might facilitate recognition and quantification of congestion, the management of which is still difficult and highly subjective. Congestion is a one of the key drivers of morbidity and mortality in patients with heart failure and is often under-recognised. The use of ultrasound allows for a timely, simultaneous identification of cardiac dysfunction and multiorgan congestion; ongoing and future studies will clarify how to tailor diuretic treatments in those with or at risk of heart failure.

Identifiants

pubmed: 37074565
doi: 10.1007/s11886-023-01865-y
pii: 10.1007/s11886-023-01865-y
doi:

Substances chimiques

Diuretics 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

411-420

Subventions

Organisme : British Heart Foundation
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Auteurs

Javed Khan (J)

NHS Tayside, Dundee, UK. drjikhan@hotmail.com.

Fraser J Graham (FJ)

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

Gabriele Masini (G)

Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy.
Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy.

Antonio Iaconelli (A)

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy.

Jocelyn M Friday (JM)

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

Chim C Lang (CC)

NHS Tayside, Dundee, UK.
Department of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK.

Pierpaolo Pellicori (P)

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH